Healthtech Startups

A biopharmaceutical company developing targeted cancer drugs and related therapies. The company focuses on drug discovery, clinical development, and commercialization to address unmet oncology needs in China and globally.

2 investors

Keeps offers prescription hair loss treatments delivered directly to customers, including a compounded 5-in-1 chewable combining dutasteride, minoxidil, biotin, vitamin C, and zinc for progressive hair loss. The company connects users with licensed clinicians who customize treatment plans and monitor progress.

2 investors

Keirón is a SaaS provider that digitizes patient-journey and administrative processes for healthcare centers, covering appointment booking, arrival, payments, consultation, quotes, and exam scheduling. Its modular software integrates with healthcare providers' IT systems to reduce wait times and improve resource management for hospitals and clinics.

2 investors

Kelonia is a biotechnology company developing next-generation genetic medicines, with a focus on cell and gene therapy programs including in vivo approaches and oncology applications. It advances therapeutic programs from preclinical research through clinical development.

2 investors

KelSie Biotech is a biotechnology company developing and commercializing drug-delivery technologies licensed from Sievers Biotech, including a Bubble Drying Process, sublingual wafers, and dry powder inhalable products. The company holds worldwide rights to formulate, sell, and sublicense finished products based on this technology and intellectual property.

2 investors

Kelsius manufactures and provides wireless temperature monitoring systems and digital HACCP task management solutions for food and life science companies. The company serves supermarket chains, restaurants, hotels, pharmaceutical manufacturers, healthcare facilities, and vaccination centres across over 50 countries, with a focus on ensuring compliance, operational efficiency, and sustainability.

2 investors

Kenai Therapeutics develops iPSC-derived cell therapies and gene-modified medicines for neurodegenerative diseases, particularly Parkinson's disease, leveraging induced pluripotent stem cell technology to replace damaged neurons and restore neural function.

2 investors

Kentegra produces concentrated liquid insecticidal extracts derived from pyrethrum flowers for use in household, agricultural, animal health, and public health pest control applications. The company's products are naturally derived, photo-degradable active ingredients suitable for formulation into consumer and professional pest management products.

2 investors

Kern Systems develops a cold data storage platform using synthetic DNA molecules and enzymes to archive data with superior density, durability, and energy efficiency compared to traditional storage technologies. The platform targets the growing market for long-term archival storage of rarely-accessed unstructured data.

2 investors

Kernel develops neurotechnology hardware, software, and research tools to measure brain activity and make brain health data accessible to research partners and clinics. Its systems are used by research institutions and clinics across the U.S., Europe, Korea, India, Canada, the U.K., and Japan.

2 investors

Keylika develops a platform synthesis technology for mixed ligand metal complexes to generate organometallic drugs for treating therapeutic conditions including hematology, pain, inflammation, metabolic disorders, infectious diseases, and oncology. The company combines drug development with drug delivery technologies, customizing molecular structure and formulation to optimize clinical outcomes for women, children, elderly, and patients with specific diseases.

2 investors

KFF is an independent organization that conducts health policy research, polling, and journalism. It provides news and analysis on healthcare policy and related topics.

2 investors

Keck Graduate Institute (KGI) is a graduate school offering master's and doctoral degree programs in fields including applied life sciences, healthcare, and lifestyle medicine. It focuses on patient-centered, career-oriented graduate education in the United States.

2 investors

Kidaura is a therapy delivery platform for childcare providers such as therapy centers and individual therapists, supporting management of child profiles, therapy scheduling, activity libraries, and progress tracking. It also facilitates communication with parents and home reinforcement of therapy skills.

2 investors

Kilo Health co-builds and invests in ventures across health, wellness, beauty, and travel, providing founders with funding, teams, operations, and full-stack support from pre-seed to Series A. Its portfolio includes digital wellness products such as a non-invasive vagus nerve stimulator with a companion app for stress relief and sleep, and probiotic supplements for gut health.

2 investors

Kin builds a tool that gives patients a clear record of every medical visit, capturing medications, instructions, follow-ups, and next steps so they can understand their care and know what to do afterward. It serves patients in the consumer healthcare space.

2 investors

Kind offers a digital care platform for healthcare providers, with features including chat messaging, video appointments, triage, custom health forms, and automated appointment reminders. It lets clinics reach patients around the clock, share information, and reduce phone time and last-minute cancellations.

2 investors

Kindra appears to be a wellness consumer brand offering clinically-tested health products with doctor recommendations. The company emphasizes clean, research-backed formulations.

2 investors

Kiniciti is a platform company that operates cell and gene therapy-focused life science businesses, including Cellistic for iPSC-based manufacturing technologies and Ncardia for human iPSC products and drug discovery services. The company serves therapeutic developers and pharmaceutical companies seeking scalable cell therapy manufacturing and drug discovery solutions.

2 investors

Kinometrix develops machine learning-based risk assessment tools for clinicians to identify patients at high risk of falls and prevent patient harm in healthcare settings. The platform integrates with electronic health records to support clinical decision-making without disrupting workflows.

2 investors

Kinoxis Therapeutics develops novel therapeutics targeting inflammatory signaling pathways in the nervous system to address unmet needs in CNS disorders, with initial focus on treatments for agitation and pain.

2 investors

Kins provides virtual and in-person physical therapy services delivered by licensed physical therapists, with specialty care for pelvic health, chronic illness, and gender-affirming care across multiple states. The company emphasizes extended appointment times and home-based exercise programs tailored to each patient's needs and available resources.

2 investors

Kipu Health provides a cloud-based platform for behavioral health providers, covering patient intake, medical records, billing, and compliance. Its software is used across addiction treatment and mental health facilities.

2 investors

Kiro is a health technology company that transforms healthcare data into actionable intelligence for patients and healthcare providers. The company analyzes patient biology over time using AI to identify patterns and support more precise, efficient care decisions.

2 investors